HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services


Download full text PDF

D. Akberova (1), A. Odintsova (2), D. Abdulganieva (1) 1 -Kazan State Medical University 2 -Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan

Autoimmune liver diseases rank fourth in the structure of liver diseases. The study of the clinical and epidemiological characteristics of these diseases makes it possible to improve their timely diagnosis and to evaluate the efficiency of therapeutic approaches. The data from the register of the Republic of Tatarstan are given in the investigation.

autoimmune liver diseases
clinical and epidemiological characteristics
ursodeoxycholic acid

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

  1. Eaton W., Pedersen M., Atladóttir H. et al. The prevalence of 30 ICD-10 autoimmune diseases in Denmark // Immunol. Res. – 2010; 47 (1–3): 228–31.
  2. Primo J., Merino C., Fernandez J. et al. Incidence and prevalenct of 2. autoimmune hepatitis in the area of the hospital de Saguto (Spain) // Gastroenterol. Hepatol. – 2004; 27 (4): 239–43.
  3. Rust Ch., Beuers U. Overlap syndromes among autoimmune liver diseases // 3. World J. Gastroenterol. – 2008; 14 (21): 3368–73.
  4. Abdollahi M., Somi M., Faraji E. Role of in international criteria the diagnosis of autoimmune hepatitis // World J. Gastroenterol. – 2013; 19 (23): 3629–33.
  5. Grigor'eva G.A., Meshalkina N.Ju. O problemah sistemnyh projavlenij vospalitel'nyh zabolevanij pecheni // Farmateka. – 2011; 15.
  6. Eaton J., Talwalkar J., Lazaridis K. et al. Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management // Gastroenterology. – 2013; 145 (3): doi:10.1053/j.gastro.2013.06.052.
  7. Liberal R., Mieli-Vergani G., Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis // J. Autoimmun. – 2013; 46: 17–24.
  8. Thomas S., Griffiths C., Smeeth L. et al. Burden of mortality associated with autoimmune diseases among females in the United Kingdom // Am. J. Public Health. – 2010; 100 (11): 2279–87.
  9. Sardu C., Cocco E., Mereu A. et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity // PLoS One. 2012; 7 (3): 32487.
  10. Walsh S., Rau L. Autoimmune disaeses: a leading cause of death among young and middle-aged women in the United States // J. Public Health. – 2000; 90: 1463–6.
  11. Grunbak L., Vilstrup H., Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A national registry-based cohort study // J. Hepatol. – 2013; Pii: SO168-8278(13)00745-9.
  12. Castro F., Lui X., Forsti A. et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease // Clin. Gastroenterol. Hepatol. – 2013; pii: S1542-3565(13)01744-8.
  13. Alvarez F., Berg P., Bianchi F. and the International Autoimmune Hepatitis Group (IAIHG). International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis // J. Hepatol. – 1999; 31: 929–38.
  14. Il'chenko L.Ju., Reshetnjak V.I. Kliniko-laboratornye kriterii diagnostiki pervichnogo biliarnogo tsirroza i sovremennaja terapija // RZhGGK. – 2011; 21 (5): 41–51.
  15. Manns M. et al. Budesonide Induces Remission MoreEffectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis // Gastroenterology. – 2010; 139: 1198–206.
  16. Hlynov I., Chikunova M. Pervichnyj biliarnyj tsirroz: kriterii dia gnostiki i sobstvennyj opyt terapii // Vrach. – 2015; 1: 44–6.
  17. Lopatkina T., Lin E., Tanaschuk E. i dr. Varianty techenija perekrestnoj formy autoimmunnyj gepatit – pervichnyj biliarnyj tsirroz // Vrach. – 2014; 1: 2–8.